about
CIViC databaseNew Molecular Considerations for Glioma: IDH, ATRX, BRAF, TERT, H3 K27M.Mass spectrometry-based assay for the molecular diagnosis of glioma: concomitant detection of chromosome 1p/19q codeletion, and IDH1, IDH2, and TERT mutation status.The effects of gene polymorphisms on glioma prognosis.Clinical and immunological correlates of long term survival in glioblastoma.Telomere Maintenance Mechanisms in Cancer.
P2860
description
2016 nî lūn-bûn
@nan
2016 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
TERT mutation in glioma: Frequency, prognosis and risk.
@ast
TERT mutation in glioma: Frequency, prognosis and risk.
@en
TERT mutation in glioma: Frequency, prognosis and risk.
@nl
type
label
TERT mutation in glioma: Frequency, prognosis and risk.
@ast
TERT mutation in glioma: Frequency, prognosis and risk.
@en
TERT mutation in glioma: Frequency, prognosis and risk.
@nl
prefLabel
TERT mutation in glioma: Frequency, prognosis and risk.
@ast
TERT mutation in glioma: Frequency, prognosis and risk.
@en
TERT mutation in glioma: Frequency, prognosis and risk.
@nl
P2093
P1476
TERT mutation in glioma: Frequency, prognosis and risk.
@en
P2093
Gou Maling
Liang Ruofei
Liu Yanhui
Luo Jiewen
Wang Xiang
P356
10.1016/J.JOCN.2015.05.066
P577
2016-04-01T00:00:00Z